Resolving mechanisms of immune-mediated disease in primary CD4 T cells

Deriving mechanisms of immune-mediated disease from GWAS data remains a formidable challenge, with attempts to identify causal variants being frequently hampered by linkage disequilibrium. To determine whether causal variants could be identified via their functional effects, we adapted a massively-parallel reporter assay for use in primary CD4 T-cells, key effectors of many immune-mediated diseases. Using the results to guide further study, we provide a generalisable framework for resolving disease mechanisms from non-coding associations – illustrated by a locus linked to 6 immune-mediated diseases, where the lead functional variant causally disrupts a super-enhancer within an NF-κB-driven regulatory circuit, triggering unrestrained T-cell activation.

[1]  Mark I. McCarthy,et al.  A brief history of human disease genetics , 2020, Nature.

[2]  Chris Wallace,et al.  Correcting the coverage of credible sets in Bayesian genetic fine-mapping , 2019, bioRxiv.

[3]  Nicholas A. Rossi,et al.  Inference of CRISPR Edits from Sanger Trace Data , 2019, bioRxiv.

[4]  Kenneth G. C. Smith,et al.  A blood-based prognostic biomarker in IBD , 2019, Gut.

[5]  C. Larminie,et al.  Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases , 2019, Nature Genetics.

[6]  Xueqi Fu,et al.  CRISPR/cas9 mediated knockout of an intergenic variant rs6927172 identified IL-20RA as a new risk gene for multiple autoimmune diseases , 2019, Genes & Immunity.

[7]  Sarah M. Goggin,et al.  High-resolution genome-wide functional dissection of transcriptional regulatory regions and nucleotides in human , 2018, Nature Communications.

[8]  J. Greenbaum,et al.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression , 2018, Cell.

[9]  David A. Knowles,et al.  Landscape of stimulation-responsive chromatin across diverse human immune cells , 2018, Nature Genetics.

[10]  Akiko Seki,et al.  Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells , 2018, The Journal of experimental medicine.

[11]  Christopher D. Brown,et al.  QuASAR‐MPRA: accurate allele‐specific analysis for massively parallel reporter assays , 2018, Bioinform..

[12]  Jonathan S. Weissman,et al.  Reprogramming human T cell function and specificity with non-viral genome targeting , 2017, Nature.

[13]  P. Gregersen,et al.  Transancestral mapping and genetic load in systemic lupus erythematosus , 2017, Nature Communications.

[14]  J. Rinn,et al.  p53 regulates enhancer accessibility and activity in response to DNA damage , 2017, Nucleic acids research.

[15]  C. Cotsapas,et al.  Integrative Genetic and Epigenetic Analysis Uncovers Regulatory Mechanisms of Autoimmune Disease. , 2017, American journal of human genetics.

[16]  P. Visscher,et al.  10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.

[17]  Hailiang Huang,et al.  Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.

[18]  D. Kono,et al.  The multiple pathways to autoimmunity , 2017, Nature Immunology.

[19]  Christopher D. Brown,et al.  QuASAR-MPRA: Accurate allele-specific analysis for massively parallel reporter assays , 2017, bioRxiv.

[20]  Sharon R Grossman,et al.  Systematic dissection of genomic features determining transcription factor binding and enhancer function , 2017, Proceedings of the National Academy of Sciences.

[21]  Alfonso Valencia,et al.  The BLUEPRINT Data Analysis Portal. , 2016, Cell systems.

[22]  Jonathan M. Cairns,et al.  Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters , 2016, Cell.

[23]  A. Barton,et al.  Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23 , 2016, Genome Biology.

[24]  T. Mikkelsen,et al.  Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions , 2016, Nature Biotechnology.

[25]  Richard Bonneau,et al.  Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation. , 2016, Cell reports.

[26]  Jacob C. Ulirsch,et al.  Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits , 2016, Cell.

[27]  Eric S. Lander,et al.  Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay , 2016, Cell.

[28]  David A. Knowles,et al.  RNA splicing is a primary link between genetic variation and disease , 2016, Science.

[29]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[30]  Chad A. Cowan,et al.  A distant trophoblast-specific enhancer controls HLA-G expression at the maternal–fetal interface , 2016, Proceedings of the National Academy of Sciences.

[31]  Kenneth G. C. Smith,et al.  Insight into Genotype-Phenotype Associations through eQTL Mapping in Multiple Cell Types in Health and Immune-Mediated Disease , 2016, PLoS genetics.

[32]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[33]  Mark I. McCarthy,et al.  Evaluating the Performance of Fine-Mapping Strategies at Common Variant GWAS Loci , 2015, PLoS genetics.

[34]  O. Troyanskaya,et al.  Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.

[35]  B. Pasaniuc,et al.  Leveraging Functional-Annotation Data in Trans-ethnic Fine-Mapping Studies. , 2015, American journal of human genetics.

[36]  S. Spicuglia.  Faculty Opinions recommendation of Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. , 2015 .

[37]  Jennifer A. Doudna,et al.  Generation of knock-in primary human T cells using Cas9 ribonucleoproteins , 2015, Proceedings of the National Academy of Sciences.

[38]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[39]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[40]  Mark S. Anderson,et al.  T cells in the control of organ-specific autoimmunity. , 2015, The Journal of clinical investigation.

[41]  Manolis Kellis,et al.  Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers , 2015, Nature Genetics.

[42]  R. Young,et al.  An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element , 2014, Science.

[43]  Andrew L. Kung,et al.  NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. , 2014, Molecular cell.

[44]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[45]  Axel Visel,et al.  Tissue-Specific RNA Expression Marks Distant-Acting Developmental Enhancers , 2014, PLoS genetics.

[46]  R. Cron,et al.  The impact of Nucleofection® on the activation state of primary human CD4 T cells. , 2014, Journal of immunological methods.

[47]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[48]  T. Meehan,et al.  An atlas of active enhancers across human cell types and tissues , 2014, Nature.

[49]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[50]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[51]  Tariq Ahmad,et al.  Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway , 2013, Cell.

[52]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[53]  Peter Donnelly,et al.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.

[54]  Judy H. Cho,et al.  Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis , 2013, Nature Genetics.

[55]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[56]  L. Chicaybam,et al.  An Efficient Low Cost Method for Gene Transfer to T Lymphocytes , 2013, PloS one.

[57]  Eli Stahl,et al.  High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis , 2012, Nature Genetics.

[58]  Jake K. Byrnes,et al.  Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.

[59]  James T. Elder,et al.  Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity , 2012, Nature Genetics.

[60]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[61]  S. Batzoglou,et al.  Linking disease associations with regulatory information in the human genome , 2012, Genome research.

[62]  Yong Zhang,et al.  Identifying ChIP-seq enrichment using MACS , 2012, Nature Protocols.

[63]  J. Todd,et al.  Seven newly identified loci for autoimmune thyroid disease , 2012, Human molecular genetics.

[64]  Jo Lambert,et al.  Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo , 2012, Nature Genetics.

[65]  Helge G. Roider,et al.  Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs , 2011, Nature Protocols.

[66]  Michael F. Melgar,et al.  Discovery of active enhancers through bidirectional expression of short transcripts , 2011, Genome Biology.

[67]  Sarah Edkins,et al.  Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease , 2011, Nature Genetics.

[68]  Miles Parkes,et al.  Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. , 2011, The Journal of clinical investigation.

[69]  Martha Bulyk,et al.  Extensive characterization of NF-κB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits , 2011, Genome Biology.

[70]  P. Gregersen,et al.  Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus , 2011, Nature Genetics.

[71]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[72]  Noula Shembade,et al.  Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes , 2010, Science.

[73]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[74]  J. Houtman,et al.  Comparison of T Cell Receptor-Induced Proximal Signaling and Downstream Functions in Immortalized and Primary T Cells , 2009, PloS one.

[75]  Jon Wakefield,et al.  Bayes factors for genome‐wide association studies: comparison with P‐values , 2009, Genetic epidemiology.

[76]  Pui-Yan Kwok,et al.  Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.

[77]  S. Gabriel,et al.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis , 2007, Nature Genetics.

[78]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[79]  C. Thompson,et al.  IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1 , 2001, The Journal of Immunology.

[80]  S. Ward,et al.  PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. , 2001, Trends in immunology.

[81]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[82]  P. Schwartzberg,et al.  Deficiency of PTEN in Jurkat T Cells Causes Constitutive Localization of Itk to the Plasma Membrane and Hyperresponsiveness to CD3 Stimulation , 2000, Molecular and Cellular Biology.

[83]  E. Zandi,et al.  The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. , 1997, Cell.

[84]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[85]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[86]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[87]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[88]  S. Ziegler,et al.  The activation antigen CD69 , 1994, Stem cells.